Inhibitory effects of the psychoactive drug modafinil on gamma-aminobutyric acid outflow from the cerebral cortex of the awake freely moving guinea-pig. Possible involvement of 5-hydroxytryptamine mechanisms
- PMID: 1620245
- DOI: 10.1007/BF00176625
Inhibitory effects of the psychoactive drug modafinil on gamma-aminobutyric acid outflow from the cerebral cortex of the awake freely moving guinea-pig. Possible involvement of 5-hydroxytryptamine mechanisms
Abstract
The effects of modafinil on acetylcholine and GABA outflow from the cerebral cortex of awake freely moving guinea pigs provided with an epidural cup were studied. In the dose range of 3-30 mg/kg s.c. modafinil produced a dose dependent significant inhibition of GABA outflow without influencing cortical acetylcholine release. Methysergide (2 mg/kg, i.p.) and ketanserin (0.5 mg/kg, i.p.) but not prazosin (0.14 mg/kg, i.p.) counteracted the inhibitory action of modafinil on cortical GABA outflow. Modafinil both acutely and chronically in the same dose range increased striatal 5-HIAA levels and 5-HT utilization in the rat (acute) and mouse (chronic). The action on cortical GABA release may be dependent on activity at 5-HT2 receptors, since the action of modafinil in this respect is blocked by the non-selective 5-HT antagonist methysergide and the 5-HT2 antagonist ketanserin. The involvement of 5-HT mechanisms in the inhibitory action of modafinil on cortical GABA release is also suggested by the findings that 5-HT metabolism may become increased by modafinil at least in the striatum. The reduction of cortical GABA outflow via 5-HT2 receptors by modafinil is probably related to some of its actions on the central nervous system including behavioural effects.
Similar articles
-
Modafinil and cortical gamma-aminobutyric acid outflow. Modulation by 5-hydroxytryptamine neurotoxins.Eur J Pharmacol. 1995 Jan 24;273(1-2):63-71. doi: 10.1016/0014-2999(94)00675-w. Eur J Pharmacol. 1995. PMID: 7737319
-
6-hydroxy-dopamine treatment counteracts the reduction of cortical GABA release produced by the vigilance promoting drug modafinil in the awake freely moving guinea-pig.Neurosci Lett. 1994 Apr 25;171(1-2):201-4. doi: 10.1016/0304-3940(94)90639-4. Neurosci Lett. 1994. PMID: 7916137
-
The vigilance promoting drug modafinil decreases GABA release in the medial preoptic area and in the posterior hypothalamus of the awake rat: possible involvement of the serotonergic 5-HT3 receptor.Neurosci Lett. 1996 Dec 6;220(1):5-8. doi: 10.1016/s0304-3940(96)13212-2. Neurosci Lett. 1996. PMID: 8977135
-
The effects of modafinil on striatal, pallidal and nigral GABA and glutamate release in the conscious rat: evidence for a preferential inhibition of striato-pallidal GABA transmission.Neurosci Lett. 1998 Sep 4;253(2):135-8. doi: 10.1016/s0304-3940(98)00629-6. Neurosci Lett. 1998. PMID: 9774168
-
Neuroprotective mechanism of modafinil on Parkinson disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.Acta Pharmacol Sin. 2004 Mar;25(3):301-5. Acta Pharmacol Sin. 2004. PMID: 15000882
Cited by
-
Evaluation of the Effect of Modafinil on Cognitive Functions in Patients with Idiopathic Hypersomnia with P300.Med Sci Monit. 2015 Jun 27;21:1850-5. doi: 10.12659/MSM.893448. Med Sci Monit. 2015. PMID: 26116438 Free PMC article.
-
Modafinil improves attentional performance in healthy, non-sleep deprived humans at doses not inducing hyperarousal across species.Neuropharmacology. 2017 Oct;125:254-262. doi: 10.1016/j.neuropharm.2017.07.031. Epub 2017 Aug 1. Neuropharmacology. 2017. PMID: 28774856 Free PMC article. Clinical Trial.
-
Modafinil, an atypical CNS stimulant?Adv Pharmacol. 2024;99:287-326. doi: 10.1016/bs.apha.2023.10.006. Epub 2023 Nov 22. Adv Pharmacol. 2024. PMID: 38467484 Free PMC article.
-
The effect of modafinil on counter-regulatory and cognitive responses to hypoglycaemia.Diabetologia. 2004 Oct;47(10):1704-11. doi: 10.1007/s00125-004-1513-5. Epub 2004 Oct 23. Diabetologia. 2004. PMID: 15517154 Clinical Trial.
-
Efficacy and safety of adjunctive modafinil treatment on residual excessive daytime sleepiness among nasal continuous positive airway pressure-treated japanese patients with obstructive sleep apnea syndrome: a double-blind placebo-controlled study.J Clin Sleep Med. 2013 Aug 15;9(8):751-7. doi: 10.5664/jcsm.2912. J Clin Sleep Med. 2013. PMID: 23946704 Free PMC article. Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources